MeSH tree: C14.280.484.048.750
A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication previously approved for adults—can safely and effectively improve the flow of blood through compromised ...
Mar 30, 2026
0
5
A Penn Medicine–led team has developed a first-of-its-kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians. Trained on more than 300,000 MRI video clips from ...
Mar 25, 2026
0
5
With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented at the EAPCI Summit 2026. The summit ...
Feb 19, 2026
0
9
A new study on aortic stenosis, the most common form of heart valve disease, has identified more than 200 new genes that predispose individuals to this condition, for which no treatment currently exists. The discovery of ...
Feb 18, 2026
0
9
Bicuspid aortic valve (BAV) is a common congenital heart defect where the aortic valve has two leaflets (cusps) instead of the usual three, resulting in abnormal blood flow and development of aortic valve diseases such as ...
Feb 11, 2026
0
9
Artificial intelligence could help doctors detect serious heart valve disease years earlier, potentially saving thousands of lives, a new study suggests. Researchers led by the University of Cambridge analyzed heart sounds ...
Feb 10, 2026
1
17
The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the finding of a new study from Uppsala University that mapped all cases of cardiomyopathy in Sweden. Despite ...
Jan 31, 2026
0
11
Williams-Beuren syndrome is a rare, congenital disease in which the main morbidity and mortality comes from obstructions, or stenoses, in specific arteries. When these obstructions involve the aorta, it is known as supravalvular ...
Jan 23, 2026
0
12
Though rare, sudden cardiac arrest (SCA) in athletes often unfolds in high-visibility settings, like sports arenas, prompting questions about underlying causes, emergency preparedness, and long-term outcomes. A new review ...
Jan 15, 2026
0
116
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to Cytokinetics.
Jan 6, 2026
0
19
